Patent · US Active

Treatment of papulopustular rosacea with ivermectin

US9782425B2 · kind B2 · utility

1Cited by

13References

22Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Jean JACOVELLA · Antibes, FR
Jean-Paul CHAPPUIS · Valbonne, FR
Alexandre KAOUKHOV · Newport Beach, US
Michael Graeber · Berlin, DE
Laurence Salin · Mougins, FR
Michel Poncet · Mougins, FR
Philippe BRIANTAIS · Antibes, FR

Key dates

Filing date	Jul 8, 2014
Grant date	Oct 10, 2017
Priority date	—
Expiry date	Jul 8, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.